IPP Bureau
SK Biopharmaceuticals joins Pharmaceutical Supply Chain Initiative
By IPP Bureau - February 25, 2022
PSCI, a global non-profit organization, works with its members to ensure a positive environment that can improve global healthcare supply chains
Actu-Real and Jehangir Clinical Dev Centre announce strategic collaboration
By IPP Bureau - February 25, 2022
The joint initiative is called J-ARC Healthcare Solutions
Canada approves plant-based Covid-19 vaccine
By IPP Bureau - February 25, 2022
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
GliaPharm SA collaborate with Wyss Centre for Alzheimer therapy
By IPP Bureau - February 25, 2022
The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers
Jardiance approved to treat adults with heart failure regardless of left ventricular ejection fraction
By IPP Bureau - February 25, 2022
Jardiance is the first and only heart failure therapy to demonstrate a statistically significant risk reduction in cardiovascular death or hospitalization for heart failure, regardless of ejection fraction
UK Vaccine Network funding for ConserV pan-coronavirus project
By IPP Bureau - February 25, 2022
UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2
Fortis Vadapalani opens Hepato-Pancreatic-Biliary and Liver transplant centre
By IPP Bureau - February 25, 2022
The dedicated HPB and liver transplant centre will be headed by Dr. Vivek Vij, Chairman -Advanced Surgical GI, HPB & Liver Transplant and his team of experts
Biohaven licenses Taldefgrobep Alfa from Bristol Myers Squibb
By IPP Bureau - February 25, 2022
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
By IPP Bureau - February 24, 2022
100% efficacy against severe Covid-19 disease and hospitalizations
Aadi Bioscience launches Fyarro in the USA
By IPP Bureau - February 24, 2022
Fyarro added to NCCN guidelines as the only preferred mTOR inhibitor to treat malignant PEComa
Novavax ships first consignment of Covid-19 vaccine to European countries
By IPP Bureau - February 24, 2022
The first wave of shipments includes several countries, such as Germany, France and Austria
Study details Proof-of-Concept for Covid-19 detection via saliva screening
By IPP Bureau - February 24, 2022
Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR
Elanco announces appointment of Rajeev (Bobby), Modi as Executive VP, U.S. Pet Health
By IPP Bureau - February 24, 2022
Modi holds a bachelor's degree in Chemical Engineering from University of Cincinnati and a master’s degree in Marketing, Management Strategy and Finance from Northwestern’s Kellogg School of Management
Philips on track with its ESG commitments
By IPP Bureau - February 24, 2022
Circular revenues already at 16% of sales, driven by healthcare informatics and services to enhance medical equipment uptime and utilization, system and software upgrades for enhanced functionality and extended lifetime and reusing refurbished parts and systems
Ruby Chandy elected to the board of Thermo Fisher Scientific
By IPP Bureau - February 24, 2022
Chandy was the president of the Industrial Division of Pall Corporation, a leading supplier of filtration, separation, and purification technologies. Previously, she was chief marketing officer at the Dow Chemical Company and Rohm and Haas Corporation
